Scientists Seek, Find, and Exploit AD Risk Genes
Using creative ways of mining genetic data, researchers are coming up with new risk variants for Alzheimer’s.
6538 RESULTS
Sort By:
Using creative ways of mining genetic data, researchers are coming up with new risk variants for Alzheimer’s.
Chemical mutagenesis yields an SOD1 variant found in people with the disease. Neurons degenerate without overexpression of the enzyme.
Researchers at CTAD advanced tau research on several fronts, correlating tau PET with Braak stage and memory loss, and introducing a new tau model and therapeutic antibody.
New therapeutics such as plant-based estrogens and neurosteroids caught notice at CTAD as an approach to try to prevent cognitive decline in women who metabolic markers indicate may be at risk for Alzheimer's.
The ALS/FTD gene produces repeat dipeptides that enter the nucleolus and kill cells within days.
Speakers at CTAD presented new treatment approaches, including a combination of two repurposed drugs that have no activity by themselves.
When provoked by Aβ, astrocytes unleash a torrent of inflammatory signals. Under it, neuronal dendrites wither and lingering synapses turn hyperactive.
In mouse models of AD, one astrocyte purinergic receptor makes glia hyperactive, while another may suppress memory. Both are upregulated in the AD brain, researchers report.
Tiny spheres full of oxygen soothe neuroinflammation and fight neurodegeneration, researchers reported at SfN. The concept may seem strange, but AD trials are on the horizon.
Scientists claim that MRI detects an Aβ oligomer-specific probe delivered to the mouse brain through the nose.
Researchers mimic neuroprotective RNAs with stable DNAs that can do the same job.
Posing as the amino acid tyrosine, the anti-aging compound resveratrol turns on a new target, PARP1.
Alzforum looks back on last year's research newsmakers.
Measuring total prion protein in cerebrospinal fluid could help clinicians differentiate between prion disease and rapidly progressing forms of dementia.
Like a second skin, a new kind of neural implant is as compliant as the protective dura membrane that envelops the central nervous system.
No filters selected